Early research (Phase 1)Study completedNCT00215956
What this trial is testing
A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma
Who this might be right for
Rectal Neoplasms
H. Lee Moffitt Cancer Center and Research Institute 31